Winthrop P. Rockefeller Cancer Institute
November 23, 2021
UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program
LITTLE ROCK — The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program.
November 15, 2021
Pioneering Researcher Returns to UAMS Myeloma Center
John D. Shaughnessy, Jr., Ph.D., has rejoined the Myeloma Center in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) as a principal staff scientist and professor of medicine. “It feels great to be back,” said Shaughnessy, whose research is focused on developing new targeted therapies for multiple myeloma,…
UAMS Receives $18.9 Million NIH Award to Address Health Disparities
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received $18.9 million from the National Institutes of Health (NIH) to support new research and interventions that will focus on reducing cancer and cardiovascular disease disparities among people who live in rural areas and African American populations across Arkansas. The five-year award from…
November 12, 2021
UAMS Biostatistics Contributes to Groundbreaking ANCHOR Study
The UAMS Department of Biostatistics played a key role in a successful national clinical trial to treat anal cancer in persons living with HIV. Jeannette Y. Lee, Ph.D., UAMS biostatistics professor and biostatistics leader for the Winthrop P. Rockefeller Cancer Institute at UAMS, served as the statistical center director for the National Cancer Institute’s (NCI)…
November 10, 2021
UAMS Raises $15 Million Toward NCI Designation
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) announced today that it has raised more than $15 million towards NCI Designation, the halfway point toward its $30 million goal.
October 28, 2021
UAMS Researchers See 12% Increase in Grant Funding for FY2021
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) and its affiliate research institutions saw research funding grow by 12.2% this past year, with $177.4 million in grants by the end of the fiscal year on June 30. It is the second consecutive year with double-digit increases in research funding that comes from…
October 27, 2021
Carol Silverstrom Trust Gives Over $1 Million to Support Nursing, Cancer Programs at UAMS
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has received gifts totaling more than $1 million from the Carol Silverstrom Trust to support the highest priorities of the UAMS College of Nursing and the Winthrop P. Rockefeller Cancer Institute. Silverstrom, who died in April, named UAMS as a beneficiary of her trust….
October 26, 2021
NCI Grant Supporting UAMS Research to Improve Cancer Treatment for Patients Lacking Good Gut Bacteria
LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team will use a National Cancer Institute (NCI) grant to study promising new ways to improve the effectiveness of a common cancer treatment for patients lacking beneficial gut bacteria. The five-year, nearly $2 million grant is led by Ruud P.M. Dings, Ph.D., M.Sc., an…
October 25, 2021
Oncologist Sindhu Malapati, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute
Sindhu Malapati, M.D., has joined the breast team in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where she is treating patients with breast cancer. “Dr. Malapati is a great addition to our team at an important time in the Cancer Institute’s growth,” said Michael Birrer, Winthrop P. …
October 21, 2021
UAMS Participating in National Breast Cancer Screening Trial
The UAMS Winthrop P. Rockefeller Cancer Institute is participating in the National Cancer Institute’s TMIST (Tomosynthesis Mammographic Imaging Screening Trial). The study compares two standard breast cancer screening methods — tomosynthesis (3D) mammograms and digital (2D) mammograms — and is designed to help researchers determine whether one method is better than the other at finding…
Previous page Next page